Topics

TetraVisc Forte Tetracaine HCI 0.5% Sterile Anesthetic Single Dose 0.6 mL | TetraVisc Forte [OCuSOFT, INC.] | BioPortfolio

12:03 EST 27th January 2019 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Tetracaine Hydrochloride 0.5% is a sterile topical ophthalmic solution useful in producing surface anesthesia of the eye. The active ingredient is represented by the structural formula:

Boric Acid; Edetate Disodium; Hypromellose; Potassium Chloride; Sodium Borate; Sodium Chloride; Water for injection USP, Hydrochloric Acid and/or Sodium Hydroxide to adjust pH.

Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% acts by decreasing the permeability of the neuronal membrane, thereby decreasing the flux of sodium, potassium and other ions associated with propagation of the nerve impulse.  The onset of anesthesia usually begins within 30 seconds and lasts a relatively short period of time.

Should not be used by the patient without physician supervision, or in those persons showing hypersensitivity to any component of this preparation.

For topical ophthalmic use only.  Not for parenteral use.  Not for injection.  Do not use solution if it contains crystals or if it is cloudy or discolored.  Prolonged use results in diminished duration of anesthesia and retarded healing.  This may cause the drug to be used more frequently, creating a "vicious circle".  Subsequent corneal infection and/or corneal opacification with accompanying permanent visual loss or corneal perforation may occur.  Prolonged use may also product severe keratitis.

Do not touch dropper tip to any surface as this may contaminate the solution.  As with all anesthetics, continuous and prolonged use should be avoided.  Protection of the eye from irritating chemicals, foreign bodies and rubbing during the period of anesthesia is very important.  Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should be used cautiously in patients with known allergy or cardiac disease.  If signs of sensitivity develop during the treatment or irritation  persists or increases, patients should be advised to discontinue use and consult prescribing physician.

Keep this and all drugs out of the reach of children.  In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.  After instillation of this product, the surface of the eye is insensitive and can be scratched without your feeling it.  Do not rub eye.  Do not instill this product repeatedly because severe eye damage may occur.

No studies have been conducted in animals or in humans to evaluate the potential of these effects.

Animal reproduction studies have not been performed with Tetracaine Hydrochloride.  It is also not known whether Tetracaine Hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction.  Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should be given to pregnant women only if clearly needed.

It is not known whether this drug is excreted in human milk.  Because many drugs are excreted in human milk, caution should be exercised when Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is administered to a nursing woman.

Safety and effectiveness in children have not been established.

Transient symptoms (signs) such as stinging, burning, and conjunctival redness may occur.  A rare, severe, immediate type allergic corneal reaction has been reported characterized by acute diffuse epithelial keratitis with filament formation and/or sloughing of large areas of necrotic epithelium, diffuse stromal edema, descemetitis and iritis.  To report SUSPECED ADVERSE REACTIONS, contact OCuSOFT, Inc. at 800-239-5469, www.ocusoft.com

Dosage: One to two drops per eye.

For Tonometry And Other Procedures Of Short Duration: Instill one or two drops just prior to evaluation.

For Minor Surgical Procedures Such As Foreign Body Or Suture Removal: Instill one or two drops in the eye(s) every five to ten minutes.  Five doses maximum.

Tetracaine Hydrochloride Ophthalmic Solution USP, 1.5% is supplied in:

    5 mL multi-drop plastic container

    Single unit dose plastic container

Store at a room temperature, 15-30 C (59- 86F).  Keep container tightly closed.

Manufacturer

OCuSOFT

Active Ingredients

Source

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Epiduo forte [galderma laboratories, l.p.]

These highlights do not include all the information needed to use EPIDUO FORTE gel safely and effectively. See full prescribing information for EPIDUO FORTE gel. EPIDUO FORTE (adapalene and benzoyl pe...

Strovite forte [everett laboratories, inc.]

STROVITE FORTE

Myferon 150 forte [martin ekwealor pharmaceuticals, inc.]

NA

Naphcon® forte(naphazoline hydrochlorideophthalmic solution usp), 0.1% [alcon]

NAPHCON® FORTE(naphazoline hydrochlorideophthalmic solution USP), 0.1%

Tetravisc forte [ocusoft, inc.]

TetraVisc Forte Tetracaine Hydrochloride Ophthalmic Solution USP, 0.5% Viscous Sterile Rx Only

Clinical Trials [49 Associated Clinical Trials listed on BioPortfolio]

Observational Program Neo-Penotran® Forte

Vaginitis is the most common gynecologic diagnosis in the primary care setting. In approximately 90 percent of affected women, this condition occurs secondary to bacterial vaginosis, vulvo...

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With EpiDuo Forte Gel

This will be an open-label study designed to assess the safety and plasma PK of topically applied IDP-126 Gel compared to Epiduo Forte Gel.

Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

The purpose of this study is to assess the efficacy of Neuroskin Forte in relieving the symptoms of dry skin in adults with psoriasis or eczema.

Evaluation of Remin Pro Forte Versus Remin Pro on Treatment of White Spot Lesions Post Orthodontic Treatment

randomized clinical trial to evaluate caries regression, the change in colour and mineral content of the demineralized enamel after treatment with Remin Pro Forte paste (fluoride, hydroxya...

Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of th...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia.

To study the efficacy and safety of Mexidol used intravenously (500 mg 1 time per day) for 14 days, followed by the oral administration of Mexidol Forte 250 in a dose of 250 mg 3 times a day for 60 da...

Tissue Response after Subcutaneous Implantation of Different Glass Ionomer-Based Cements.

The aim of this study was to evaluate the subcutaneous connective tissue response of isogenic mice after implantation of different glass ionomer-based cements (EQUIA® Forte Fil, EQUIA® Fil and Ketac...

DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.

Swine influenza virus (SIVs) infections cause a significant economic impact to the pork industry. Moreover, pigs may act as mixing vessel favoring genome reassortment of diverse influenza viruses. Suc...

Quick Search

Relevant Topics

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Anesthesia
Anesthesia is the loss of feeling or sensation in all or part of the body. It may result from damage to nerves or can be induced by an anesthetist (a medical professional) using anesthetics such as thiopental or propofol or sevoflurane during a surgical ...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record